Pubdate: Wed, 22 Mar 2000 Source: New York Times (NY) Copyright: 2000 The New York Times Company Contact: 229 West 43rd Street, New York, NY 10036 Fax: (212) 556-3622 Website: http://www.nytimes.com/ Forum: http://www10.nytimes.com/comment/ Author: Linda Greenhouse REBUFFING CLINTON, JUSTICES LIMIT F.D.A. ON TOBACCO WASHINGTON, March 21 - The Supreme Court today dealt a sharp blow to the Clinton administration's efforts to curb smoking, ruling 5 to 4 that the Food and Drug Administration had never received authority from Congress to regulate tobacco products. The decision, rejecting rules proposed by the agency in 1995 to restrict the marketing of cigarettes to children and teenagers, hands the question of national tobacco regulation back to Congress. An effort to confer jurisdiction on the Food and Drug Administration won some bipartisan support in Congress in 1998 but became mired in a broader debate over whether to give the cigarette industry immunity from damage suits. The ruling today was notable for the strong language that both the majority and the dissenting opinions used in describing the dangers of smoking, which causes some 400,000 deaths a year in the United States. Although essentially a straightforward ruling on a question of administrative law, the decision paid more than usual attention to the underlying policy issues, as if in recognition that the debate will continue elsewhere. [The ruling, essentially a decision to keep the tobacco industry alive, had an immediate effect on the industry, News Analysis. It also prompted immediate comments from Vice President Al Gore and Gov. George W. Bush.] Justice Sandra Day O'Connor, who said in her majority opinion that the food and drug agency had "amply demonstrated" that tobocco use was "perhaps the single most significant threat to public health in the United States," sounded at times almost apologetic for her conclusion that the Food, Drug and Cosmetic Act, which the agency used to assert jurisdiction, could not be stretched far enough to accommodate the regulations. In the dissenting opinion, Justice Stephen G. Breyer said that given nicotine's highly addictive nature and the "life-threatening harms" of smoking, the Food and Drug Administration's authority should be interpreted in light of "its basic purpose - the overall protection of public health." He said the court should avoid an "overly rigid" interpretation of the Food, Drug and Cosmetic Act "that is divorced from the statute's overall health-protecting purposes." Dr. David A. Kessler, the former Food and Drug Administration commissioner who led the agency in reversing its long-held position that it could not regulate tobacco, said today that the loss in court had "in some ways moved the issue forward" through the justices' recognition of the dimensions of the problem as a public health issue. "We're in a very different place than we were five years ago," Dr. Kessler, now the dean of Yale Medical School, said in an interview. The majority today applied a settled principle of administrative law: if Congress has spoken clearly on a question of an agency's jurisdiction, or lack of jurisdiction, Congress has the last word. "The F.D.A.'s claim to jurisdiction contravenes the clear intent of Congress," Justice O'Connor said. The dispute between the majority and dissent was over the clarity of Congress's intent, which the dissent found to be much less evident. The decision upheld a 1998 ruling by the United States Court of Appeals for the Fourth Circuit, in Richmond. Four cigarette manufacturers - the Brown and Williamson Tobacco Corporation, a division of British American Tobacco P.L.C.; the Philip Morris Companies; the Lorillard Tobacco Company, which is a division of Loew's, and the United States Tobacco Company - along with the National Association of Convenience Stores had gone to federal court to challenge the regulations as soon as the food and drug agency formally issued them in 1996. A 1997 ruling by Judge William L. Osteen Sr. of Federal District Court in Greensboro, N.C., upheld the agency's jurisdiction over controlling children's access to cigarettes, but struck down the regulations' restrictions on advertising and promotion. Under the authority of the district court's decision, the agency has since 1997 been spending about $34 million a year on contracts with the 50 states to help monitor compliance with state laws barring the sale of cigarettes to those under 18. The agency began today to send letters to the states announcing an "orderly shutdown" of the compliance program in light of the Supreme Court ruling. The majority opinion today, Food and Drug Administration v. Brown & Williamson, No. 98-1152, was joined by Chief Justice William H. Rehnquist and by Justices Antonin Scalia, Anthony M. Kennedy and Clarence Thomas. Justices John Paul Stevens, David H. Souter and Ruth Bader Ginsburg joined Justice Breyer's dissenting opinion. This particular 5-to-4 split has become familiar in the last few years, with the more conservative justices on one side and the relatively more liberal ones on the other. Yet there was nothing overtly ideological about the essentially historical question of whether a 1938 statute, or any subsequent legislative developments, conferred jurisdiction on a federal agency. But a distrust of the power of administrative agencies has long been a watchword of legal conservatives, and this case reached the court within a broader context of renewed ferment over the constitutional boundaries of the modern administrative state. The federal appeals court here issued a startling decision last year, holding that in authorizing the Environmental Protection Agency to issue certain regulations under the Clean Air Act, Congress engaged in an unconstitutional "delegation" of its legislative powers to an executive branch agency. As the justices were undoubtedly aware, the Clinton administration has recently asked them to review that ruling. In his dissenting opinion today, Justice Breyer appeared to go out of his way to refute any suggestion that an agency's action is insulated from political accountability. "Insofar as the decision to regulate tobacco reflects the policy of an administration, it is a decision for which that administration, and those politically elected officials who support it, must (and will) take responsibility," Justice Breyer said, adding: "I do not believe that an administrative agency decision of this magnitude - - one that is important, conspicuous, and controversial - can escape the kind of public scrutiny that is essential in any democracy." The Food and Drug Administration regulations were based on the premise that most people who become lifelong smokers start smoking in their early teens. To discourage teenage smoking, the regulations prohibited the sale of cigarettes to those under 18; the distribution of free samples or the sale of packages of fewer than 20 cigarettes; and the use of self-service displays or vending machines except in adults-only locations. Retailers were required to verify, through photo identification, the age of all purchasers younger than 27. There were also restrictions on outdoor advertising near playgrounds and schools and on promotional items and sponsorship of various events by cigarette companies. The agency claimed its authority under the Food, Drug and Cosmetic Act, which gives it jurisdiction to regulate "drugs" and "devices." Drugs are defined in the 1938 law as articles, other than food, "intended to affect the structure or any function of the body." Nicotine was such a substance, the agency said, and cigarettes were devices for delivering nicotine. The agency's assertion of authority over tobacco in 1995 came after decades of disclaiming such jurisdiction. The agency justified its about-face by pointing to newly disclosed internal cigarette industry documents showing that the industry understood and intended to achieve nicotine's effects - thus meeting for the first time the statute's requirement that any effect be intentional. The tobacco industry objected immediately that Congress had never meant to give the Food and Drug Administration jurisdiction over tobacco. Parsing the statute, industry lawyers provided a syllogism that the majority today found persuasive. The agency's core mission, the industry argued, was to make sure that drugs reaching the market were safe and effective. Because the agency found cigarettes to be unsafe, it was required under the law not simply to regulate them but to ban them. But, the argument went on, Congress clearly did not intend that result, because since 1938, it has passed a half-dozen measures dealing with smoking that were obviously based on the assumption that cigarettes would continue to be marketed. The notion that the agency could treat tobacco as it would an ordinary drug was simply misbegotten, the industry said. Adopting that argument, Justice O'Connor said today that "the inescapable conclusion is that there is no room for tobacco products" within the law's structure. "If they cannot be used safely for any therapeutic purpose, and yet they cannot be banned, they simply do not fit," she said. Where the majority found certainty, the dissent found Congress's treatment of smoking to be "critically ambivalent" in several important respects. For administrative law purposes, the difference between Congressional clarity and ambiguity is crucial, because once the court decides that Congress has spoken ambiguously about an agency's authority, its precedents require judges to defer to the agency's view of the matter. - --- MAP posted-by: Jo-D